Sign in

CIK 0001819576 · Non-accelerated filer

Liquidia Corp

Sign in to watch
Ticker
LQDA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
851710962
Phone
919.328.4400
Business address
419 DAVIS DRIVE, SUITE 100, MORRISVILLE, NC, 27560
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$23,494,367
in 17 filings, $12.2M under 10b5-1 plans

Net −$23,494,367. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-08-21 Adair Jason Chief Business Officer Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 −238 0
2026-08-20 Rielly-Gauvin Katherine Director Option exercise 10b5-1 +11,727 $2.51 $29K 56,364
2026-08-20 Rielly-Gauvin Katherine Director Option exercise 10b5-1 +6,666 $2.59 $17K 63,030
2026-08-20 Rielly-Gauvin Katherine Director Sale 10b5-1 −18,393 $72.23 $1.3M 44,637
2026-08-20 Rielly-Gauvin Katherine Director Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 −11,727 0
2026-08-20 Rielly-Gauvin Katherine Director Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 −6,666 0
2026-08-19 Rielly-Gauvin Katherine Director Option exercise 10b5-1 +23,455 $2.51 $59K 68,092
2026-08-19 Rielly-Gauvin Katherine Director Option exercise 10b5-1 +13,334 $2.59 $35K 81,426
2026-08-19 Rielly-Gauvin Katherine Director Sale 10b5-1 −36,789 $74.99 $2.8M 44,637
2026-08-19 Rielly-Gauvin Katherine Director Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 −23,455 11,727
2026-08-19 Rielly-Gauvin Katherine Director Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 −13,334 6,666
2026-08-19 Saggar Rajeev Chief Medical Officer Option exercise +50,000 $3.73 $187K 192,265
2026-08-19 Saggar Rajeev Chief Medical Officer Sale −50,000 $74.06 $3.7M 142,265
2026-08-19 Saggar Rajeev Chief Medical Officer Option exercise · Non-Qualified Stock Option (right to buy) −50,000 150,000
2026-08-17 Saggar Rajeev Chief Medical Officer Sale −29,534 $76.84 $2.3M 142,265
2026-07-27 Boyle Dana Chief Accounting Officer Sale 10b5-1 −1,600 $87.53 $140K 167,919
2026-07-27 Adair Jason Chief Business Officer Sale 10b5-1 −688 $87.53 $60K 216,438
2026-07-23 Bloch Stephen M Director Sale −96,400 $89.44 $8.6M 505,077
2026-07-23 Bloch Stephen M Director Sale −3,600 $90.71 $327K 501,477
2026-07-22 Bloch Stephen M Director Sale −37,406 $87.70 $3.3M 664,071

Page 4 of 18 · 344 trades